Inhalation aid
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view, as viewed from the left, of an inhalation aid showing our new design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a right side elevational view, the left side elevational view being a mirror image thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a top plan view thereof; and,
FIG. 6 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D352999
Type: Grant
Filed: Jul 16, 1993
Date of Patent: Nov 29, 1994
Assignee: Glaxo Group Limited (Greenfield)
Inventors: James H. Nicholson (Rickmansworth), Michael McCurry (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 0/10,776
Type: Grant
Filed: Jul 16, 1993
Date of Patent: Nov 29, 1994
Assignee: Glaxo Group Limited (Greenfield)
Inventors: James H. Nicholson (Rickmansworth), Michael McCurry (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 0/10,776
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)